Eli Lilly & Company and ScinoPharm Taiwan Ltd. announced today that they have reached an amicable resolution of all ongoing patent litigations between the companies relating to ScinoPharm's manufacture and sale of gemcitabine hydrochloride around the world.
The details can be read here.
No comments:
Post a Comment